ACORDA THERAPEUTICS (NASDAQ:ACOR)

23.90

+0.25 (1.06%)

ACORDA THERAPEUTICS (NASDAQ:ACOR) Delayed :
Previous Close	$23.65	52 Week High	$29.27
Open	$23.48	52 Week Low	$14.42
Day High	$24.09	P/E	N/A
Day Low	$23.13	EPS	$-2.17
Volume	619,604
More ACOR Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
BIIB	4	ELN	3
SLTM	3	TBSI	2
SRZ	2	LNC	2
KCP	2	CXM	2
BKD	2	AMLN	2
CAGC	2	MPG	2

View All Entities

Nov 3, 2009 07:56 AM Acorda Thera (ACOR) Posts Q3 Loss of $0.51, 8c Better than Estimates
Oct 15, 2009 06:32 AM FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS
Jul 1, 2009 07:22 AM Acorda (ACOR) Enters License Agreement With Biogen Idec (BIIB) For Fampridine-SR Outside the U.S.

Nov 4, 2009 08:31 AM Acorda Therapeutic (ACOR) volatility at 55 into extension of PDUFA
Nov 3, 2009 07:56 AM Acorda Thera (ACOR) Posts Q3 Loss of $0.51, 8c Better than Estimates
Nov 2, 2009 01:40 PM Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
Oct 22, 2009 09:58 AM Acorda Therapeutics (ACOR) Announces that US FDA Extended Fampridine-SR Review Date
Oct 15, 2009 01:26 PM Unusual 11 Mid-Day Movers 10/15: ACOR, LTON, RUBO, SLTM, MPG Higher; STSA, CXM, MNI, RAMS Lower

Nov 16, 2009 10:02AM Acorda Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
Nov 3, 2009 06:00AM Acorda Therapeutics Reports Third Quarter 2009 Financial Results
Oct 27, 2009 07:00AM Acorda Therapeutics to Host Conference Call to Report Third Quarter 2009 Financial Results on November 3, 2009
Oct 22, 2009 06:00AM Acorda Therapeutics Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010
Oct 14, 2009 07:22PM Acorda Therapeutics Announces Positive Vote by FDA Advisory Committee for Fampridine-SR

Oct 18, 2009 09:29 AM On Small Cap Drug Makers and Volatility
Oct 15, 2009 06:40 PM Equities Update: Late Rally
Oct 15, 2009 11:35 AM Analyst upgrades, downgrades and initiations: ACOR, BHI, HAL, LAZ, SLB, TRV ...
Oct 15, 2009 04:14 AM Positive FDA Panel Outcome for Acorda Therapeutics
Oct 12, 2009 05:16 PM A Mixed Bag for Traders and Investors in Healthcare

ANDREW OLIVER SATCHELL
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
Naj Alikhan
on Nov 6, 2009
at 09:06 AM famridene Very exciting news. I have PPMS. When will it be available in the UK?
Article: FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS
Naj Alikhan
on Nov 6, 2009
at 09:06 AM famridene Very exciting news. I have PPMS. When will it be available in the UK?
Article: FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS
Judith A. Schlining
on Nov 3, 2009
at 11:02 AM Famridene I am 63 yrs old and have had MS sincew I was in my twenty's. Walking has become very hard for me due to fatigue and pain. Will fsmridene help e to have a more active life. I would love to play with my Grandchildren or go shopping.
Article: FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS
Carol LaGrave
on Nov 2, 2009
at 08:52 PM I have PPMS Walking is becoming more and more difficult. The best news I have heard since I was diagnoised 2 years ago.
Article: FDA Panel Backs Acorda's (ACOR) Fampridine-SR for MS

View All Comments

No comments are currently available.